• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人发生痴呆症和轻度认知障碍的终生风险。

Lifetime risk of incident dementia and incident mild cognitive impairment in older adults.

作者信息

Du Lianlian, Yu Lei, Wang Tianhao, Boyle Patricia A, Barnes Lisa L, Marquez David X, Bennett David A

机构信息

Rush Alzheimer's Disease Center, Rush University Medical Center; Chicago, IL, USA.

Department of Neurological Sciences, Rush University Medical Center; Chicago, IL, USA.

出版信息

medRxiv. 2025 Sep 4:2025.08.29.25334749. doi: 10.1101/2025.08.29.25334749.

DOI:10.1101/2025.08.29.25334749
PMID:40950465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12424864/
Abstract

BACKGROUND AND OBJECTIVES

To estimate the lifetime risk of dementia and mild cognitive impairment (MCI) from age 55 to 105, accounting for competing risk of death, and to examine differences by sex and race.

METHODS

We analyzed data from five harmonized longitudinal cohort studies at the Rush Alzheimer's Disease Center, including 4611 community dwelling older adults for lifetime dementia risk estimation and 3915 for lifetime MCI risk estimation. Incident dementia and MCI were identified through annual clinical evaluations. Nonparametric cumulative incidence function curves estimated lifetime risk, adjusting for competing risk of death and left truncation. Additional analyses assessed lifetime risk from index ages 55, 65, 75, and 85 and examined differences by sex and race.

RESULTS

The lifetime risk of incident dementia after age 55 was 43% (95% CI: 38-47), with a median age at diagnosis of 88 years(IQR: 83-92). For MCI, the lifetime risk was 62% (95% CI: 57-67), with a median age at diagnosis of 86 years(IQR: 80-90). Females had higher lifetime risks than males for both dementia (45% vs. 39%) and MCI (63% vs. 60%). Racial differences were smaller for dementia (45% in Black vs. 44% in White participants). For MCI, Black adults had higher lifetime risk before age 90.

DISCUSSION

These findings extend dementia lifetime risk estimation beyond age 90 among diverse older adults to provide lifetime risk estimates for MCI while accounting for the competing risk of death, highlighting the importance of prevention, and equitable public health strategies to reduce the burden of cognitive impairment.

摘要

背景与目的

估计55岁至105岁人群患痴呆症和轻度认知障碍(MCI)的终生风险,同时考虑死亡的竞争风险,并研究性别和种族差异。

方法

我们分析了拉什阿尔茨海默病中心五项协调的纵向队列研究的数据,其中4611名社区居住的老年人用于终生痴呆症风险估计,3915名用于终生MCI风险估计。通过年度临床评估确定新发痴呆症和MCI。非参数累积发病率函数曲线估计终生风险,并对死亡的竞争风险和左截断进行调整。额外的分析评估了55岁、65岁、75岁和85岁起始年龄的终生风险,并研究了性别和种族差异。

结果

55岁以后患新发痴呆症的终生风险为43%(95%CI:38-47),诊断时的中位年龄为88岁(IQR:83-92)。对于MCI,终生风险为62%(95%CI:57-67),诊断时的中位年龄为86岁(IQR:80-90)。女性患痴呆症(45%对39%)和MCI(63%对60%)的终生风险均高于男性。痴呆症的种族差异较小(黑人参与者为45%,白人参与者为44%)。对于MCI,黑人成年人在90岁之前的终生风险较高。

讨论

这些发现将痴呆症终生风险估计扩展到90岁以上的不同老年人,同时考虑死亡的竞争风险,为MCI提供终生风险估计,强调了预防以及公平的公共卫生策略对减轻认知障碍负担的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c6/12424864/b8bf4d7c49e5/nihpp-2025.08.29.25334749v3-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c6/12424864/613821d2d8c8/nihpp-2025.08.29.25334749v3-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c6/12424864/ceb3d7e1e1d4/nihpp-2025.08.29.25334749v3-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c6/12424864/b8bf4d7c49e5/nihpp-2025.08.29.25334749v3-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c6/12424864/613821d2d8c8/nihpp-2025.08.29.25334749v3-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c6/12424864/ceb3d7e1e1d4/nihpp-2025.08.29.25334749v3-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c6/12424864/b8bf4d7c49e5/nihpp-2025.08.29.25334749v3-f0003.jpg

相似文献

1
Lifetime risk of incident dementia and incident mild cognitive impairment in older adults.老年人发生痴呆症和轻度认知障碍的终生风险。
medRxiv. 2025 Sep 4:2025.08.29.25334749. doi: 10.1101/2025.08.29.25334749.
2
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
3
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
4
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
5
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
6
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
7
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).用于检测轻度认知障碍(MCI)患者中阿尔茨海默病及其他痴呆症的简易精神状态检查表(MMSE)。
Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2.
8
Multi-domain interventions for the prevention of dementia and cognitive decline.多领域干预措施预防痴呆和认知能力下降。
Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013572. doi: 10.1002/14651858.CD013572.pub2.
9
The Association of Dementia and Mild Cognitive Impairment With Outpatient Ambulatory Care Utilization in the Community.社区中痴呆症和轻度认知障碍与门诊流动护理利用的关联
J Am Geriatr Soc. 2025 Mar 22. doi: 10.1111/jgs.19446.
10
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.加兰他敏治疗阿尔茨海默病所致痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.

本文引用的文献

1
Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individuals.黑人和白人个体血浆 Aβ42/40 的基线水平和纵向变化。
Nat Commun. 2024 Jul 2;15(1):5539. doi: 10.1038/s41467-024-49859-w.
2
Age of Diabetes Diagnosis and Lifetime Risk of Dementia: The Atherosclerosis Risk in Communities (ARIC) Study.糖尿病诊断年龄与痴呆终身风险:动脉粥样硬化风险社区研究(ARIC)。
Diabetes Care. 2024 Sep 1;47(9):1576-1583. doi: 10.2337/dc24-0203.
3
Alzheimer's disease as a women's health challenge: a call for action on integrative precision medicine approaches.
阿尔茨海默病作为一项女性健康挑战:呼吁对整合精准医学方法采取行动。
NPJ Womens Health. 2024;2(1):17. doi: 10.1038/s44294-024-00021-3. Epub 2024 May 20.
4
2024 Alzheimer's disease facts and figures.2024 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2024 May;20(5):3708-3821. doi: 10.1002/alz.13809. Epub 2024 Apr 30.
5
Identification of Dementia in Medicare Claims Compared to Rigorous Clinical Assessments in African Americans.与严格的临床评估相比,医疗保险索赔中对非裔美国人的痴呆症识别。
J Gerontol A Biol Sci Med Sci. 2024 Jan 1;79(1). doi: 10.1093/gerona/glad235.
6
Designing the next-generation clinical care pathway for Alzheimer's disease.设计阿尔茨海默病的下一代临床护理路径。
Nat Aging. 2022 Aug;2(8):692-703. doi: 10.1038/s43587-022-00269-x. Epub 2022 Aug 19.
7
Neuroanatomical correlates of genetic risk for obesity in children.儿童肥胖遗传风险的神经解剖学相关性。
Transl Psychiatry. 2023 Jan 3;13(1):1. doi: 10.1038/s41398-022-02301-5.
8
Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US: The 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol Project.估算美国痴呆症和轻度认知障碍的患病率:2016 年健康退休研究协调认知评估方案项目。
JAMA Neurol. 2022 Dec 1;79(12):1242-1249. doi: 10.1001/jamaneurol.2022.3543.
9
Racial differences in longitudinal Alzheimer's disease biomarkers among cognitively normal adults.认知正常成年人纵向阿尔茨海默病生物标志物的种族差异。
Alzheimers Dement. 2022 Dec;18(12):2570-2581. doi: 10.1002/alz.12608. Epub 2022 Feb 25.
10
A comparison of statistical methods to predict the residual lifetime risk.统计方法预测剩余寿命风险的比较。
Eur J Epidemiol. 2022 Feb;37(2):173-194. doi: 10.1007/s10654-021-00815-8. Epub 2022 Jan 3.